title: An Italian perspective: studying the cost-effectiveness of sofosbuvir before completion of national price negotiations.
authors.affiliation: HTA Unit, ESTAV Toscana Centro, Regional Health Service, Firenze, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Messori
authors.forename: Dario
authors.initials: D
authors.lastname: Maratea
authors.forename: Valeria
authors.initials: V
authors.lastname: Fadda
authors.forename: Roberta
authors.initials: R
authors.lastname: Gatto
authors.forename: Sabrina
authors.initials: S
authors.lastname: Trippoli
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000331:legislation & jurisprudence*; D017850:Economics, Pharmaceutical / Q000331:legislation & jurisprudence*; D006801:Humans; D007558:Italy; D009313:National Health Programs / Q000191:economics*; D017008:Negotiating; D000069474:Sofosbuvir; D014542:Uridine Monophosphate / Q000031:analogs & derivatives* / Q000191:economics / Q000600:supply & distribution
chemical_list: D014542:Uridine Monophosphate; D000069474:Sofosbuvir